Search Results 81-90 of 16283 for Levomilnacipran

  1. Drugs and Supplements that Start with F - Mayo Clinic

    Levomilnacipran (oral route). Fetzima Titration Pack. Also known as. Levomilnacipran (oral route). Feverall. Also known as. Acetaminophen (oral route, rectal ...

  2. Rituximab Plus Lenalidomide for Patients With Relapsed / Refractory Indolent Non-Hodgkin's Lymphoma (Follicular Lymphoma and Marginal Zone Lymphoma) - Mayo Clinic

    This double-blind randomized, parallel group study will evaluate the efficacy and safety of lenalidomide (Revlimid, CC-5013) in combination with rituximab ( ...

  3. Sumatriptan (nasal route) - Side effects & dosage - Mayo Clinic

    Levomilnacipran. Show More. Other Interactions. Certain medicines should not be used at or around the time of eating food or eating certain types of food since ...

  4. https://www.mayoclinic.org/chinese_patient_consumer_faq.xml

  5. Hodgkin Clinical Trials - Mayo Clinic Research

    This phase I trial studies the side effects and the best dose of everolimus when given together with brentuximab vedotin in treating patients with Hodgkin ...

  6. Rizatriptan (oral route) - Side effects & dosage - Mayo Clinic

    Levomilnacipran; Levorphanol; Lisdexamfetamine; Lithium; Lofepramine. Show More. Other Interactions. Certain medicines should not be used at or around the time ...

  7. A Study of Levosimendan in Pulmonary Hypertension (PH) with Heart Failure (HF) and Preserved Left Ventricular Ejection Fraction (pEF) Patients - Mayo Clinic

    A Study of Levosimendan in Pulmonary Hypertension (PH) with Heart Failure (HF) and Preserved Left Ventricular Ejection Fraction (pEF) Patients · Overview.

  9. Sumatriptan (transdermal route) - Side effects & dosage - Mayo Clinic

    Levomilnacipran; Levorphanol. Show More. Other Interactions. Certain medicines should not be used at or around the time of eating food or eating certain types ...

  10. A Study Of The Drugs Selumetinib Vs. Carboplatin And Vincristine In Patients With Low-Grade Glioma - Mayo Clinic

    About this study. This study aims to demonstrate that the efficacy of treatment with selumetinib as measured by event-free survival (EFS) is non-inferior ...